The coronavirus outbreak is a make-or-break moment for healthcare companies. UBS shares 2 resilient stocks worth buying — and 7 to avoid at all costs.

6:15am PDT - March 8th, 2020    abbott stock - Business Insider

There have been few winners in the stock market recently, but Matthew Taylor of UBS says there are a few medical technology companies that could benefit from the response to the coronavirus outbreak. Just as importantly, there are some companies in the indust…